古典的豚フィーバーワクチンの世界市場調査レポート2023年版Global Classical Swine Fever Vaccines Market Research Report 2023 古典的豚フィーバーワクチンの世界市場は、2022年に1億5470万米ドルと評価され、2029年には2億1100万米ドルに達すると予測され、予測期間2023-2029年に4.6%のCAGRを目撃しています。COVID-19とオランダ・ウクライ... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー古典的豚フィーバーワクチンの世界市場は、2022年に1億5470万米ドルと評価され、2029年には2億1100万米ドルに達すると予測され、予測期間2023-2029年に4.6%のCAGRを目撃しています。COVID-19とオランダ・ウクライナ戦争の影響は、市場規模を推定する際に考慮した。古典的豚熱ワクチンの北米市場は、2023年から2029年の予測期間中に3.22%のCAGRで、2023年の1229万ドルから増加し、2029年には1486万ドルに達すると推定されます。 古典的豚熱ワクチンのアジア太平洋市場は、2023年の1億400万ドルから、2023年から2029年の予測期間中に5.17%のCAGRで、2029年までに1億4070万ドルに達すると推定されます。 古典的豚熱ワクチンの世界の主要メーカーは、WINSUN、Boehringer Ingelheim、CAHIC、SPAH、Merck、Ceva、Harbin Veterinary Research Institute、Qilu Animal Health Products Factoryなどです。2022年には、世界のトップ5ベンダーが売上の約50.49%を占めています。 レポートスコープ 当レポートは、古典的豚フィーバーワクチンの世界市場を量的・質的分析により包括的に提示し、読者がビジネス/成長戦略の策定、市場競争状況の把握、現在の市場における自社のポジション分析、古典的豚フィーバーワクチンに関する十分なビジネス判断を下すための一助とすることを目的としています。 古典的豚フィーバーワクチンの市場規模、推計、予測は、2021年を基準年とみなし、2017年から2028年までの期間の履歴と予測データを売上数量(M Doses)と収益($ million)で提供しています。本レポートでは、世界の古典的豚フィーバーワクチン市場を包括的に区分しています。地域別の市場規模、供給元別製品に関するもの、販売チャネル別、プレイヤー別のものも掲載しています。 市場をより深く理解するために、競争環境、主要な競合企業、それぞれの市場ランクなどのプロフィールを掲載しています。また、技術動向や新製品開発についても解説しています。 本レポートは、企業別、供給元別、販売チャネル別、地域別など、異なるセグメントにわたる市場全体とサブセグメントの収益、販売量、平均価格に関する情報を提供し、この市場における古典的豚熱ワクチンのメーカー、新規参入企業、産業チェーン関連企業のお役に立ちたいと思います。 会社別 ウィンスン ベーリンガーインゲルハイム カヒック スパハ メルク セヴァ ハルビン獣医学研究院 斉魯動物衛生製品工場 リングプの生物学 ディーエイチエヌ キャバク コミファーマ アグロベット ビオベータ 金渝バイオテクノロジー(Jinyu Bio-Technology Institutul Pasteur 最優秀選手 テコン ソース別セグメント 組織培養の起源 細胞株由来 販売チャネル別セグメント 政府入札 市場販売 地域別消費量 北アメリカ U.S. カナダ メキシコ アジア太平洋 中国 日本 南朝鮮 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス イギリス イタリア ロシア その他のヨーロッパ 南米 ブラジル その他の南米地域 コアチャプター 第1章:報告書のスコープ、異なる市場セグメント(地域別、製品タイプ別、用途別など)のエグゼクティブサマリー、各市場セグメントの市場規模、将来の発展可能性などを紹介します。市場の現状と、短中期および長期的にどのような進化を遂げる可能性があるのかについて、ハイレベルな視点を提供しています。 第2章:古典的豚フィーバーワクチンメーカーの競争環境、価格、販売・収益シェア、最新の開発計画、M&A情報などを詳細に分析します。 第3章:古典的豚フィーバーワクチンの地域レベル、国レベルの売上、収益。各地域とその主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来の発展展望、市場空間、市場規模を紹介します。 第4章:ソース別に様々な市場セグメントの分析を提供し、各市場セグメントの市場規模や発展可能性を網羅し、読者が異なる市場セグメントにおけるブルーオーシャン市場を見つけることができるようにします。 第5章:読者が異なる下流市場でブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの市場規模や発展の可能性をカバーする、販売チャネル別の様々な市場セグメントの分析を提供します。 第6章:主要企業のプロフィールを提供し、製品の売上、収益、価格、粗利益率、製品紹介、最近の開発など、市場の主要企業の基本状況を詳細に紹介する。 第7章:産業の上流と下流を含む産業チェーンの分析。 第8章:市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析などを紹介する。 第9章:本レポートの要点と結論。 目次1 Classical Swine Fever Vaccines Market Overview 11.1 Product Definition 1 1.2 Classical Swine Fever Vaccines by Source 1 1.2.1 Global Classical Swine Fever Vaccines Market Value Comparison by Source (2023-2029) 2 1.2.2 Tissue Culture Origin 3 1.2.3 Cell Line Origin 4 1.3 Classical Swine Fever Vaccines by Sales Channel 5 1.3.1 Global Classical Swine Fever Vaccines Market Value by Sales Channel (2023-2029) 5 1.3.2 Government Tender 7 1.3.3 Market Sales 8 1.4 Global Classical Swine Fever Vaccines Market Size Estimates and Forecasts 8 1.4.1 Global Classical Swine Fever Vaccines Revenue 2018-2029 8 1.4.2 Global Classical Swine Fever Vaccines Sales 2018-2029 10 1.4.3 Global Classical Swine Fever Vaccines Market Average Price (2018-2029) 11 1.5 Assumptions and Limitations 11 2 Classical Swine Fever Vaccines Market Competition by Manufacturers 14 2.1 Global Classical Swine Fever Vaccines Sales Market Share by Manufacturers (2018-2023) 14 2.2 Global Classical Swine Fever Vaccines Revenue Market Share by Manufacturers (2019-2023) 17 2.3 Global Classical Swine Fever Vaccines Average Price by Manufacturers (2019-2023) 20 2.4 Global Key Players of Classical Swine Fever Vaccines, Industry Ranking, 2021 VS 2022 22 2.5 Global Key Manufacturers of Classical Swine Fever Vaccines, Area Served & Headquarters 23 2.6 Global Key Manufacturers of Classical Swine Fever Vaccines, Product Type & Application 24 2.7 Founded Data of Global Key Classical Swine Fever Vaccines Manufacturers 25 2.8 Global Classical Swine Fever Vaccines Market Competitive Situation and Trends 26 2.8.1 Global Classical Swine Fever Vaccines Market Concentration Rate 26 2.8.2 The Global 5 and 10 Largest Classical Swine Fever Vaccines Players Market Share by Revenue 27 2.8.3 Global Classical Swine Fever Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) 28 3 Global Classical Swine Fever Vaccines Market Scenario by Region 30 3.1 Global Classical Swine Fever Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029 30 3.2 Global Classical Swine Fever Vaccines Sales by Region: 2018-2029 31 3.2.1 Global Classical Swine Fever Vaccines Sales by Region: 2018-2023 31 3.2.2 Global Classical Swine Fever Vaccines Sales by Region: 2024-2029 32 3.3 Global Classical Swine Fever Vaccines Revenue by Region: 2018-2029 33 3.3.1 Global Classical Swine Fever Vaccines Revenue by Region: 2018-2023 33 3.3.2 Global Classical Swine Fever Vaccines Revenue by Region: 2024-2029 33 3.4 North America Classical Swine Fever Vaccines Market Facts & Figures by Country 34 3.4.1 North America Classical Swine Fever Vaccines Market Size by Country: 2018 VS 2022 VS 2029 34 3.4.2 North America Classical Swine Fever Vaccines Sales by Country (2018-2029) 35 3.4.3 North America Classical Swine Fever Vaccines Revenue by Country (2018-2029) 36 3.4.4 U.S. 38 3.4.5 Canada 38 3.4.6 Mexico 39 3.5 Europe Classical Swine Fever Vaccines Market Facts & Figures by Country 39 3.5.1 Europe Classical Swine Fever Vaccines Market Size by Country: 2018 VS 2022 VS 2029 39 3.5.2 Europe Classical Swine Fever Vaccines Sales by Country (2018-2029) 40 3.5.3 Europe Classical Swine Fever Vaccines Revenue by Country (2018-2029) 41 3.5.4 Germany 43 3.5.5 France 43 3.5.6 U.K. 44 3.5.7 Italy 44 3.5.8 Russia 45 3.6 Asia Pacific Classical Swine Fever Vaccines Market Facts & Figures by Region 45 3.6.1 Asia Pacific Classical Swine Fever Vaccines Market Size by Region: 2018 VS 2022 VS 2029 45 3.6.2 Asia Pacific Classical Swine Fever Vaccines Sales by Region (2018-2029) 46 3.6.3 Asia Pacific Classical Swine Fever Vaccines Revenue by Region (2018-2029) 47 3.6.4 China 49 3.6.5 Japan 49 3.6.6 South Korea 50 3.6.7 India 50 3.6.8 Australia 51 3.6.9 Southeast Asia 51 3.7 South America Classical Swine Fever Vaccines Market Facts & Figures by Country 52 3.7.1 South America Classical Swine Fever Vaccines Market Size by Country: 2018 VS 2022 VS 2029 52 3.7.2 South America Classical Swine Fever Vaccines Sales by Country (2018-2029) 52 3.7.3 South America Classical Swine Fever Vaccines Revenue by Country 53 3.7.4 Brazil 54 3.8 Middle East and Africa Classical Swine Fever Vaccines Market Facts & Figures by Country 54 3.8.1 Middle East and Africa Classical Swine Fever Vaccines Market Size by Country: 2018 VS 2022 VS 2029 54 3.8.2 Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2018-2029) 55 3.8.3 Middle East and Africa Classical Swine Fever Vaccines Revenue by Country 56 3.8.4 Middle East 57 3.8.5 Africa 58 4 Segment by Source 59 4.1 Global Classical Swine Fever Vaccines Sales by Source (2018-2029) 59 4.1.1 Global Classical Swine Fever Vaccines Sales by Source (2018-2023) 59 4.1.2 Global Classical Swine Fever Vaccines Sales by Source (2024-2029) 59 4.1.3 Global Classical Swine Fever Vaccines Sales Market Share by Source (2018-2029) 59 4.2 Global Classical Swine Fever Vaccines Revenue by Source (2018-2029) 61 4.2.1 Global Classical Swine Fever Vaccines Revenue by Source (2018-2023) 61 4.2.2 Global Classical Swine Fever Vaccines Revenue by Source (2024-2029) 61 4.2.3 Global Classical Swine Fever Vaccines Revenue Market Share by Source (2018-2029) 61 4.3 Global Classical Swine Fever Vaccines Price by Source (2018-2029) 62 5 Segment by Sales Channel 64 5.1 Global Classical Swine Fever Vaccines Sales by Sales Channel (2018-2029) 64 5.1.1 Global Classical Swine Fever Vaccines Sales by Sales Channel (2018-2023) 64 5.1.2 Global Classical Swine Fever Vaccines Sales by Sales Channel (2024-2029) 64 5.1.3 Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2018-2029) 64 5.2 Global Classical Swine Fever Vaccines Revenue by Sales Channel (2018-2029) 66 5.2.1 Global Classical Swine Fever Vaccines Revenue by Sales Channel (2018-2023) 66 5.2.2 Global Classical Swine Fever Vaccines Revenue by Sales Channel (2024-2029) 66 5.2.3 Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2018-2029) 66 5.3 Global Classical Swine Fever Vaccines Price by Sales Channel (2018-2029) 68 6 Key Companies Profiled 69 6.1 WINSUN 69 6.1.1 WINSUN Company Information 69 6.1.2 WINSUN Description and Business Overview 69 6.1.3 WINSUN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 70 6.1.4 WINSUN Classical Swine Fever Vaccines Product Portfolio 71 6.2 Boehringer Ingelheim 71 6.2.1 Boehringer Ingelheim Company Information 72 6.2.2 Boehringer Ingelheim Description and Business Overview 72 6.2.3 Boehringer Ingelheim Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 73 6.2.4 Boehringer Ingelheim Classical Swine Fever Vaccines Product Portfolio 73 6.3 CAHIC 74 6.3.1 CAHIC Company Information 75 6.3.2 CAHIC Description and Business Overview 75 6.3.3 CAHIC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 76 6.3.4 CAHIC Classical Swine Fever Vaccines Product Portfolio 76 6.4 SPAH 77 6.4.1 SPAH Company Information 78 6.4.2 SPAH Description and Business Overview 78 6.4.3 SPAH Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 79 6.4.4 SPAH Classical Swine Fever Vaccines Product Portfolio 79 6.5 Merck 80 6.5.1 Merck Company Information 80 6.5.2 Merck Description and Business Overview 81 6.5.3 Merck Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 82 6.5.4 Merck Classical Swine Fever Vaccines Product Portfolio 82 6.6 Ceva 82 6.6.1 Ceva Company Information 83 6.6.2 Ceva Description and Business Overview 83 6.6.3 Ceva Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 84 6.6.4 Ceva Classical Swine Fever Vaccines Product Portfolio 84 6.7 Harbin Veterinary Research Institute 85 6.7.1 Harbin Veterinary Research Institute Company Information 85 6.7.2 Harbin Veterinary Research Institute Description and Business Overview 86 6.7.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 87 6.7.4 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product Portfolio 87 6.8 Qilu Animal Health Products Factory 88 6.8.1 Qilu Animal Health Products Factory Company Information 88 6.8.2 Qilu Animal Health Products Factory Description and Business Overview 88 6.8.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 89 6.8.4 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product Portfolio 89 6.9 Ringpu Biology 90 6.9.1 Ringpu Biology Company Information 90 6.9.2 Ringpu Biology Description and Business Overview 90 6.9.3 Ringpu Biology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 91 6.9.4 Ringpu Biology Classical Swine Fever Vaccines Product Portfolio 92 6.10 DHN 92 6.10.1 DHN Company Information 92 6.10.2 DHN Description and Business Overview 93 6.10.3 DHN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 94 6.10.4 DHN Classical Swine Fever Vaccines Product Portfolio 94 6.11 CAVAC 95 6.11.1 CAVAC Company Information 95 6.11.2 CAVAC Description and Business Overview 96 6.11.3 CAVAC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 97 6.11.4 CAVAC Classical Swine Fever Vaccines Product Portfolio 97 6.12 Komipharm 98 6.12.1 Komipharm Company Information 98 6.12.2 Komipharm Description and Business Overview 99 6.12.3 Komipharm Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 99 6.12.4 Komipharm Classical Swine Fever Vaccines Product Portfolio 100 6.13 Agrovet 100 6.13.1 Agrovet Company Information 101 6.13.2 Agrovet Description and Business Overview 101 6.13.3 Agrovet Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 102 6.13.4 Agrovet Classical Swine Fever Vaccines Product Portfolio 103 6.14 Bioveta 103 6.14.1 Bioveta Company Information 103 6.14.2 Bioveta Description and Business Overview 104 6.14.3 Bioveta Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 104 6.14.4 Bioveta Classical Swine Fever Vaccines Product Portfolio 105 6.15 Jinyu Bio-Technology 105 6.15.1 Jinyu Bio-Technology Company Information 105 6.15.2 Jinyu Bio-Technology Description and Business Overview 106 6.15.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 106 6.15.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Product Portfolio 107 6.16 Institutul Pasteur 107 6.16.1 Institutul Pasteur Company Information 107 6.16.2 Institutul Pasteur Description and Business Overview 108 6.16.3 Institutul Pasteur Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 109 6.16.4 Institutul Pasteur Classical Swine Fever Vaccines Product Portfolio 109 6.17 MVP 110 6.17.1 MVP Company Information 110 6.17.2 MVP Description and Business Overview 110 6.17.3 MVP Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 111 6.17.4 MVP Classical Swine Fever Vaccines Product Portfolio 111 6.18 Tecon 111 6.18.1 Tecon Company Information 112 6.18.2 Tecon Description and Business Overview 112 6.18.3 Tecon Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 113 6.18.4 Tecon Classical Swine Fever Vaccines Product Portfolio 113 7 Industry Chain and Sales Channels Analysis 114 7.1 Classical Swine Fever Vaccines Industry Chain Analysis 114 7.2 Classical Swine Fever Vaccines Key Raw Materials 115 7.2.1 Key Raw Materials 115 7.2.2 Raw Materials Key Suppliers 115 7.3 Classical Swine Fever Vaccines Production Mode & Process 117 7.4 Classical Swine Fever Vaccines Sales and Marketing 118 7.4.1 Classical Swine Fever Vaccines Sales Channels 118 7.4.2 Classical Swine Fever Vaccines Distributors 119 7.5 Classical Swine Fever Vaccines Customers 121 8 Classical Swine Fever Vaccines Market Dynamics 124 8.1 Classical Swine Fever Vaccines Industry Trends 124 8.2 Classical Swine Fever Vaccines Market Drivers 125 8.3 Classical Swine Fever Vaccines Market Challenges 126 8.4 Classical Swine Fever Vaccines Market Restraints 126 9 Research Findings and Conclusion 127 10 Methodology and Data Source 129 10.1 Methodology/Research Approach 129 10.1.1 Research Programs/Design 129 10.1.2 Market Size Estimation 130 10.1.3 Market Breakdown and Data Triangulation 131 10.2 Data Source 132 10.2.1 Secondary Sources 132 10.2.2 Primary Sources 133 10.3 Author List 135 10.4 Disclaimer 138
SummaryThe global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2022 and is anticipated to reach US$ 211 million by 2029, witnessing a CAGR of 4.6% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Table of Contents1 Classical Swine Fever Vaccines Market Overview 11.1 Product Definition 1 1.2 Classical Swine Fever Vaccines by Source 1 1.2.1 Global Classical Swine Fever Vaccines Market Value Comparison by Source (2023-2029) 2 1.2.2 Tissue Culture Origin 3 1.2.3 Cell Line Origin 4 1.3 Classical Swine Fever Vaccines by Sales Channel 5 1.3.1 Global Classical Swine Fever Vaccines Market Value by Sales Channel (2023-2029) 5 1.3.2 Government Tender 7 1.3.3 Market Sales 8 1.4 Global Classical Swine Fever Vaccines Market Size Estimates and Forecasts 8 1.4.1 Global Classical Swine Fever Vaccines Revenue 2018-2029 8 1.4.2 Global Classical Swine Fever Vaccines Sales 2018-2029 10 1.4.3 Global Classical Swine Fever Vaccines Market Average Price (2018-2029) 11 1.5 Assumptions and Limitations 11 2 Classical Swine Fever Vaccines Market Competition by Manufacturers 14 2.1 Global Classical Swine Fever Vaccines Sales Market Share by Manufacturers (2018-2023) 14 2.2 Global Classical Swine Fever Vaccines Revenue Market Share by Manufacturers (2019-2023) 17 2.3 Global Classical Swine Fever Vaccines Average Price by Manufacturers (2019-2023) 20 2.4 Global Key Players of Classical Swine Fever Vaccines, Industry Ranking, 2021 VS 2022 22 2.5 Global Key Manufacturers of Classical Swine Fever Vaccines, Area Served & Headquarters 23 2.6 Global Key Manufacturers of Classical Swine Fever Vaccines, Product Type & Application 24 2.7 Founded Data of Global Key Classical Swine Fever Vaccines Manufacturers 25 2.8 Global Classical Swine Fever Vaccines Market Competitive Situation and Trends 26 2.8.1 Global Classical Swine Fever Vaccines Market Concentration Rate 26 2.8.2 The Global 5 and 10 Largest Classical Swine Fever Vaccines Players Market Share by Revenue 27 2.8.3 Global Classical Swine Fever Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) 28 3 Global Classical Swine Fever Vaccines Market Scenario by Region 30 3.1 Global Classical Swine Fever Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029 30 3.2 Global Classical Swine Fever Vaccines Sales by Region: 2018-2029 31 3.2.1 Global Classical Swine Fever Vaccines Sales by Region: 2018-2023 31 3.2.2 Global Classical Swine Fever Vaccines Sales by Region: 2024-2029 32 3.3 Global Classical Swine Fever Vaccines Revenue by Region: 2018-2029 33 3.3.1 Global Classical Swine Fever Vaccines Revenue by Region: 2018-2023 33 3.3.2 Global Classical Swine Fever Vaccines Revenue by Region: 2024-2029 33 3.4 North America Classical Swine Fever Vaccines Market Facts & Figures by Country 34 3.4.1 North America Classical Swine Fever Vaccines Market Size by Country: 2018 VS 2022 VS 2029 34 3.4.2 North America Classical Swine Fever Vaccines Sales by Country (2018-2029) 35 3.4.3 North America Classical Swine Fever Vaccines Revenue by Country (2018-2029) 36 3.4.4 U.S. 38 3.4.5 Canada 38 3.4.6 Mexico 39 3.5 Europe Classical Swine Fever Vaccines Market Facts & Figures by Country 39 3.5.1 Europe Classical Swine Fever Vaccines Market Size by Country: 2018 VS 2022 VS 2029 39 3.5.2 Europe Classical Swine Fever Vaccines Sales by Country (2018-2029) 40 3.5.3 Europe Classical Swine Fever Vaccines Revenue by Country (2018-2029) 41 3.5.4 Germany 43 3.5.5 France 43 3.5.6 U.K. 44 3.5.7 Italy 44 3.5.8 Russia 45 3.6 Asia Pacific Classical Swine Fever Vaccines Market Facts & Figures by Region 45 3.6.1 Asia Pacific Classical Swine Fever Vaccines Market Size by Region: 2018 VS 2022 VS 2029 45 3.6.2 Asia Pacific Classical Swine Fever Vaccines Sales by Region (2018-2029) 46 3.6.3 Asia Pacific Classical Swine Fever Vaccines Revenue by Region (2018-2029) 47 3.6.4 China 49 3.6.5 Japan 49 3.6.6 South Korea 50 3.6.7 India 50 3.6.8 Australia 51 3.6.9 Southeast Asia 51 3.7 South America Classical Swine Fever Vaccines Market Facts & Figures by Country 52 3.7.1 South America Classical Swine Fever Vaccines Market Size by Country: 2018 VS 2022 VS 2029 52 3.7.2 South America Classical Swine Fever Vaccines Sales by Country (2018-2029) 52 3.7.3 South America Classical Swine Fever Vaccines Revenue by Country 53 3.7.4 Brazil 54 3.8 Middle East and Africa Classical Swine Fever Vaccines Market Facts & Figures by Country 54 3.8.1 Middle East and Africa Classical Swine Fever Vaccines Market Size by Country: 2018 VS 2022 VS 2029 54 3.8.2 Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2018-2029) 55 3.8.3 Middle East and Africa Classical Swine Fever Vaccines Revenue by Country 56 3.8.4 Middle East 57 3.8.5 Africa 58 4 Segment by Source 59 4.1 Global Classical Swine Fever Vaccines Sales by Source (2018-2029) 59 4.1.1 Global Classical Swine Fever Vaccines Sales by Source (2018-2023) 59 4.1.2 Global Classical Swine Fever Vaccines Sales by Source (2024-2029) 59 4.1.3 Global Classical Swine Fever Vaccines Sales Market Share by Source (2018-2029) 59 4.2 Global Classical Swine Fever Vaccines Revenue by Source (2018-2029) 61 4.2.1 Global Classical Swine Fever Vaccines Revenue by Source (2018-2023) 61 4.2.2 Global Classical Swine Fever Vaccines Revenue by Source (2024-2029) 61 4.2.3 Global Classical Swine Fever Vaccines Revenue Market Share by Source (2018-2029) 61 4.3 Global Classical Swine Fever Vaccines Price by Source (2018-2029) 62 5 Segment by Sales Channel 64 5.1 Global Classical Swine Fever Vaccines Sales by Sales Channel (2018-2029) 64 5.1.1 Global Classical Swine Fever Vaccines Sales by Sales Channel (2018-2023) 64 5.1.2 Global Classical Swine Fever Vaccines Sales by Sales Channel (2024-2029) 64 5.1.3 Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2018-2029) 64 5.2 Global Classical Swine Fever Vaccines Revenue by Sales Channel (2018-2029) 66 5.2.1 Global Classical Swine Fever Vaccines Revenue by Sales Channel (2018-2023) 66 5.2.2 Global Classical Swine Fever Vaccines Revenue by Sales Channel (2024-2029) 66 5.2.3 Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2018-2029) 66 5.3 Global Classical Swine Fever Vaccines Price by Sales Channel (2018-2029) 68 6 Key Companies Profiled 69 6.1 WINSUN 69 6.1.1 WINSUN Company Information 69 6.1.2 WINSUN Description and Business Overview 69 6.1.3 WINSUN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 70 6.1.4 WINSUN Classical Swine Fever Vaccines Product Portfolio 71 6.2 Boehringer Ingelheim 71 6.2.1 Boehringer Ingelheim Company Information 72 6.2.2 Boehringer Ingelheim Description and Business Overview 72 6.2.3 Boehringer Ingelheim Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 73 6.2.4 Boehringer Ingelheim Classical Swine Fever Vaccines Product Portfolio 73 6.3 CAHIC 74 6.3.1 CAHIC Company Information 75 6.3.2 CAHIC Description and Business Overview 75 6.3.3 CAHIC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 76 6.3.4 CAHIC Classical Swine Fever Vaccines Product Portfolio 76 6.4 SPAH 77 6.4.1 SPAH Company Information 78 6.4.2 SPAH Description and Business Overview 78 6.4.3 SPAH Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 79 6.4.4 SPAH Classical Swine Fever Vaccines Product Portfolio 79 6.5 Merck 80 6.5.1 Merck Company Information 80 6.5.2 Merck Description and Business Overview 81 6.5.3 Merck Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 82 6.5.4 Merck Classical Swine Fever Vaccines Product Portfolio 82 6.6 Ceva 82 6.6.1 Ceva Company Information 83 6.6.2 Ceva Description and Business Overview 83 6.6.3 Ceva Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 84 6.6.4 Ceva Classical Swine Fever Vaccines Product Portfolio 84 6.7 Harbin Veterinary Research Institute 85 6.7.1 Harbin Veterinary Research Institute Company Information 85 6.7.2 Harbin Veterinary Research Institute Description and Business Overview 86 6.7.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 87 6.7.4 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product Portfolio 87 6.8 Qilu Animal Health Products Factory 88 6.8.1 Qilu Animal Health Products Factory Company Information 88 6.8.2 Qilu Animal Health Products Factory Description and Business Overview 88 6.8.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 89 6.8.4 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product Portfolio 89 6.9 Ringpu Biology 90 6.9.1 Ringpu Biology Company Information 90 6.9.2 Ringpu Biology Description and Business Overview 90 6.9.3 Ringpu Biology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 91 6.9.4 Ringpu Biology Classical Swine Fever Vaccines Product Portfolio 92 6.10 DHN 92 6.10.1 DHN Company Information 92 6.10.2 DHN Description and Business Overview 93 6.10.3 DHN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 94 6.10.4 DHN Classical Swine Fever Vaccines Product Portfolio 94 6.11 CAVAC 95 6.11.1 CAVAC Company Information 95 6.11.2 CAVAC Description and Business Overview 96 6.11.3 CAVAC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 97 6.11.4 CAVAC Classical Swine Fever Vaccines Product Portfolio 97 6.12 Komipharm 98 6.12.1 Komipharm Company Information 98 6.12.2 Komipharm Description and Business Overview 99 6.12.3 Komipharm Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 99 6.12.4 Komipharm Classical Swine Fever Vaccines Product Portfolio 100 6.13 Agrovet 100 6.13.1 Agrovet Company Information 101 6.13.2 Agrovet Description and Business Overview 101 6.13.3 Agrovet Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 102 6.13.4 Agrovet Classical Swine Fever Vaccines Product Portfolio 103 6.14 Bioveta 103 6.14.1 Bioveta Company Information 103 6.14.2 Bioveta Description and Business Overview 104 6.14.3 Bioveta Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 104 6.14.4 Bioveta Classical Swine Fever Vaccines Product Portfolio 105 6.15 Jinyu Bio-Technology 105 6.15.1 Jinyu Bio-Technology Company Information 105 6.15.2 Jinyu Bio-Technology Description and Business Overview 106 6.15.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 106 6.15.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Product Portfolio 107 6.16 Institutul Pasteur 107 6.16.1 Institutul Pasteur Company Information 107 6.16.2 Institutul Pasteur Description and Business Overview 108 6.16.3 Institutul Pasteur Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 109 6.16.4 Institutul Pasteur Classical Swine Fever Vaccines Product Portfolio 109 6.17 MVP 110 6.17.1 MVP Company Information 110 6.17.2 MVP Description and Business Overview 110 6.17.3 MVP Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 111 6.17.4 MVP Classical Swine Fever Vaccines Product Portfolio 111 6.18 Tecon 111 6.18.1 Tecon Company Information 112 6.18.2 Tecon Description and Business Overview 112 6.18.3 Tecon Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2019-2023) 113 6.18.4 Tecon Classical Swine Fever Vaccines Product Portfolio 113 7 Industry Chain and Sales Channels Analysis 114 7.1 Classical Swine Fever Vaccines Industry Chain Analysis 114 7.2 Classical Swine Fever Vaccines Key Raw Materials 115 7.2.1 Key Raw Materials 115 7.2.2 Raw Materials Key Suppliers 115 7.3 Classical Swine Fever Vaccines Production Mode & Process 117 7.4 Classical Swine Fever Vaccines Sales and Marketing 118 7.4.1 Classical Swine Fever Vaccines Sales Channels 118 7.4.2 Classical Swine Fever Vaccines Distributors 119 7.5 Classical Swine Fever Vaccines Customers 121 8 Classical Swine Fever Vaccines Market Dynamics 124 8.1 Classical Swine Fever Vaccines Industry Trends 124 8.2 Classical Swine Fever Vaccines Market Drivers 125 8.3 Classical Swine Fever Vaccines Market Challenges 126 8.4 Classical Swine Fever Vaccines Market Restraints 126 9 Research Findings and Conclusion 127 10 Methodology and Data Source 129 10.1 Methodology/Research Approach 129 10.1.1 Research Programs/Design 129 10.1.2 Market Size Estimation 130 10.1.3 Market Breakdown and Data Triangulation 131 10.2 Data Source 132 10.2.1 Secondary Sources 132 10.2.2 Primary Sources 133 10.3 Author List 135 10.4 Disclaimer 138
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(抗生物薬)の最新刊レポートQYResearch 社の最新刊レポート本レポートと同じKEY WORD(swine)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/12 10:27 143.85 円 158.71 円 190.22 円 |